Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study
Open Access
- 5 June 2025
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 1-11
Abstract
Background: Use of long-acting injectable antiretroviral therapy (LA-ART) for human immunodeficiency virus (HIV) treatment and prevention is increasing, but there are challenges that could limit broad expansion of these important treatments. The goal of this study was to explore attitudes, barriers, and facilitators for implementing LA-ART administration within community pharmacies. Methods: We conducted a mixed-methods study focusing on pre-implementation aspects of community pharmacy-administered LA-ART. Pharmacists, clinic staff members, and persons with HIV completed a baseline survey followed by an individual semi-structured qualitative interview with questions based on the Consolidated Framework for Implementation Research (CFIR v.1.0). Results: A total of 63 participants (pharmacist n = 19, clinic staff n = 20, person with HIV n = 24) from Alabama, California, Florida, and Texas were included in the study. Most pharmacist participants were employed in retail pharmacies that processed fewer than 500 prescriptions per day (75%) and most had more than 10 years of experience working with people with HIV (53%). Clinic staff participants were also highly experienced in working with people with HIV (55%). People with HIV enrolled in the study were either on oral antiretroviral therapy but interested in LA-ART (59%) or were already on LA-ART (29%). Clinics were the preferred location for LA-ART administration while community pharmacy was the second preferred location. Attitudes regarding pharmacy-based administration of LA-ART were mostly positive, with the primary facilitator being positive experiences or established relationships between clinics and pharmacies or persons with HIV and their pharmacies. Barriers included concerns about pharmacy staffing, training, space, privacy, and pharmacy reimbursement for services. Conclusion: Involving community pharmacies in the administration of LA-ART could expand access to HIV treatment and prevention medications. Outlining best practices that leverage facilitators and overcome barriers can help clinics, pharmacy, and communities expand this novel model of care. Trial registration: ClinicalTrials.Gov Registration: NCT05152953 (posted 12/10/2021).Keywords
All Related Versions
Funding Information
- ViiV Healthcare
This publication has 26 references indexed in Scilit:
- Implementation of a Pharmacist-Led, Long-Acting, Injectable Cabotegravir/Rilpivirine Program for HIV-1 at Health System-Based Clinics in the New York Metropolitan AreaAIDS Patient Care and STDs, 2024
- Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of Human Immunodeficiency Virus (HIV) in High-Income CountriesClinical Infectious Diseases, 2022
- First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV ClinicClinical Infectious Diseases, 2022
- Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care SitesOpen Forum Infectious Diseases, 2022
- Effect of pharmacist care on clinical outcomes among people living with HIV/AIDS: A systematic review and meta-analysisResearch in Social and Administrative Pharmacy, 2022
- Evaluation of patient satisfaction and perceptions of a long-acting injectable antipsychotic medication administration service in a community-based pharmacy during the COVID-19 pandemicJournal of the American Pharmacists Association, 2022
- Attitudes about community pharmacy access to HIV prevention medications in CaliforniaJournal of the American Pharmacists Association, 2020
- Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacyJournal of the American Pharmacists Association, 2018
- How to Construct a Mixed Methods Research DesignKölner Zeitschrift für Soziologie und Sozialpsychologie, 2017
- Thematic analysis.2012